Allovir Inc (ALVR)

12:21 PM

Kalaris and AlloVir Announce Stockholder Approval of Merger - Vision Monday

12:21 PM

Mar 12, 2025

AlloVir shareholders approve merger with Kalaris Therapeutics By Investing.com - Investing.com Australia

Mar 12, 2025

Mar 12, 2025

AlloVir Stockholders Approve Key Amendment and Merger - TipRanks

Mar 12, 2025

Mar 12, 2025

AlloVir shareholders approve merger with Kalaris Therapeutics - Investing.com India

Mar 12, 2025

Mar 12, 2025

Stockholders Approve Game-Changing Kalaris-AlloVir Merger: What This Means for Retinal Disease Treatment - StockTitan

Mar 12, 2025

Mar 09, 2025

AlloVir (ALVR) Expected to Announce Earnings on Thursday - Defense World

Mar 09, 2025

Mar 07, 2025

AlloVir Inc. (ALVR) reports earnings - Quartz

Mar 07, 2025

Mar 07, 2025

Allovir, Inc. SEC 10-K Report - TradingView

Mar 07, 2025

Mar 06, 2025

How To Trade (ALVR) - Stock Traders Daily

Mar 06, 2025

Mar 03, 2025

DEADLINE ALERT: Bernstein Liebhard LLP Reminds AlloVir, Inc. Investors of Upcoming Deadline - ACCESS Newswire

Mar 03, 2025

Feb 28, 2025

FINAL ALVR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 28, 2025

Feb 27, 2025

Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

Investors who lost money on AlloVir, Inc. (ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - ACCESS Newswire

Feb 27, 2025

Feb 25, 2025

$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of ALVR, IPG, AVAV, WMPN to Act Now - TradingView

Feb 25, 2025

Feb 25, 2025

Allovir’s chief accounting officer sells $967 in stock - Investing.com India

Feb 25, 2025

Feb 24, 2025

Allovir general counsel Edward Miller sells $1,068 in stock By Investing.com - Investing.com Canada

Feb 24, 2025

Feb 24, 2025

Allovir’s chief accounting officer sells $967 in stock By Investing.com - Investing.com Nigeria

Feb 24, 2025

Feb 24, 2025

Allovir's chief accounting officer sells $967 in stock By Investing.com - Investing.com Australia

Feb 24, 2025

Feb 24, 2025

Allovir’s Vikas Sinha sells shares worth $3,052 By Investing.com - Investing.com Nigeria

Feb 24, 2025

Feb 24, 2025

Allovir’s Vikas Sinha sells shares worth $3,052 - Investing.com

Feb 24, 2025

Feb 24, 2025

Allovir general counsel Edward Miller sells $1,068 in stock - Investing.com

Feb 24, 2025

Feb 24, 2025

Allovir's Vikas Sinha sells shares worth $3,052 - Investing.com India

Feb 24, 2025

Feb 20, 2025

Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - ACCESS Newswire

Feb 20, 2025

Feb 19, 2025

ALVR SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 19, 2025

Feb 19, 2025

UPCOMING ALVR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 19, 2025

Feb 13, 2025

$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of EMKR, CCRN, WMPN, ALVR to Act Now - GlobeNewswire Inc.

Feb 13, 2025

Feb 13, 2025

(ALVR) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 13, 2025

Feb 12, 2025

AlloVir (NASDAQ:ALVR) Stock Price Up 0.5%Should You Buy? - MarketBeat

Feb 12, 2025

Feb 11, 2025

IMMINENT ALVR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AlloVir Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 11, 2025

Feb 10, 2025

ALLOVIR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AlloVir, Inc.ALVR - Business Wire

Feb 10, 2025

Feb 08, 2025

AlloVir (NASDAQ:ALVR) Stock Price Up 0.5% – Should You Buy? - Defense World

Feb 08, 2025

Feb 07, 2025

$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of OMIC, BERY, WMPN, ALVR to Act Now - The Malaysian Reserve

Feb 07, 2025

Jan 28, 2025

Allovir director Vikas Sinha sells $1,225 in stock - MSN

Jan 28, 2025

Jan 28, 2025

Allovir's chief accounting officer sells $342 in common stock - MSN

Jan 28, 2025

Jan 28, 2025

Allovir's general counsel sells $494 in stock - MSN

Jan 28, 2025

Jan 27, 2025

Allovir's general counsel sells $494 in stock By Investing.com - Investing.com South Africa

Jan 27, 2025

Jan 27, 2025

Allovir's chief accounting officer sells $342 in common stock By Investing.com - Investing.com South Africa

Jan 27, 2025

Jan 27, 2025

Allovir director Vikas Sinha sells $1,225 in stock By Investing.com - Investing.com Australia

Jan 27, 2025

Jan 27, 2025

Levi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming Deadline - GuruFocus.com

Jan 27, 2025

Jan 26, 2025

Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineALVR - ACCESS Newswire

Jan 26, 2025

Jan 22, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCYTH, ALVR, WMPN, OMC - Morningstar

Jan 22, 2025

Jan 21, 2025

ALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Inve - GuruFocus.com

Jan 21, 2025

Jan 18, 2025

AlloVir (NASDAQ:ALVR) Trading 8.2% HigherHere's What Happened - MarketBeat

Jan 18, 2025

Jan 17, 2025

The Law Offices of Vincent Wong Remind AlloVir Investors of a Lead Plaintiff Deadline of March 19, 2024 - Marketscreener.com

Jan 17, 2025

Jan 17, 2025

AlloVir (NASDAQ:ALVR) Hits New 1-Year LowWhat's Next? - MarketBeat

Jan 17, 2025